CN Bio Email Formats
Biotechnology Research • 
Cambridge, England, United Kingdom • 51-100 Employees
CN Bio Email Formats
CN Bio uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@cn-bio.com), used 62.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@cn-bio.com | 62.1% |
{first name}.{last name} | john.doe@cn-bio.com | 37.9% |
Key Contacts at CN Bio
Neil Rumbelow
Director Engineering & Production
Paul Brooks
Chief Executive Officer
Joe Parisi
Director Of Sales, Americas
Sung Lee
Director Of Product Management
Sarah Payne
Marketing Director
Adrian Rea
Director Of Sales & Business Development - Emea & Apac
Steven Lane
Finance Director
Company overview
| Headquarters | 332 Cambridge Science Park, Milton Road, Cambridge, England CB4 0WN, GB |
| Phone number | +446517359 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Drug Discovery, Bioavailability, Disease Modeling, Preclinical Drug Discovery, 3D Cell Culture, Liver Disease, Adme, Drug Metabolism, Hepatitis B, Respiratory Infection, Contract Research Services, Dili, Organ-On-A-Chip, Containment Level 3 Laboratory, Microfluidic Cell Culture, Non-Alcoholic Steatohepatitis, Precision Biology, Covid 19, Microphysiological Systems, Organ-On-Chip, Drug-Induced Liver Injury, Safety Toxicology, Aminal Alternative, New Alternative Approaches, Physiomimix Ooc, Non-Alcoholic Fatty Liver Disorder, Drug Absorption |
| Founded | 2008 |
| Employees | 51-100 |
| Socials |
About CN Bio
CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery. Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market more rapidly, cost-effectively and using fewer animals. Utilizing primary cells, our perfused single (Lung, Liver), and multi-organ (Intestine/Liver, Lung/Liver) models recapitulate the microarchitecture, microenvironment and function of their human counterparts in vitro. The approach provides a viable alternative to animal models where translatability to humans is predicted to be poor and for testing advanced drug modalities where human-specific targets and pathways are required. They generate physiologically relevant, human-translatable, mechanistic data that enables researchers to progress only the safest and most efficacious drugs into in vivo animal studies and be better prepared for clinical trials. Please follow us for regular updates. It starts here.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
CN Bio has 27 employees across 10 departments.
Departments
Number of employees
Funding Data
Explore CN Bio's funding history, including investment rounds, total capital raised, and key backers.
CN Bio Tech Stack
Discover the technologies and tools that power CN Bio's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Analytics
Caching
Analytics
JavaScript libraries
CDN
WordPress themes
JavaScript libraries
Advertising
Miscellaneous
Denmark
Austria
Frequently asked questions
4.8
40,000 users
